This program seeks applications from all areas of basic and preclinical research, and strongly encourages applications that address the critical needs of the ASD community in the following areas (listed alphabetically):
• Tests of implementation strategies to increase use of evidence-based practices
• Assessment of novel therapeutics using valid preclinical models
• Mechanisms of heterogeneous clinical expression of ASD
• Environmental risk factors
• Improve diagnosis across the life span
• Factors promoting success in key transitions to independence for individuals living with ASD
• Development of healthcare provider-focused training or tools to improve healthcare delivery for individuals with ASD across the life span and the continuum of care (i.e., primary care, urgent/emergent care, and disaster relief)
• Cultural, socioeconomic, and gender factors in diagnosis, treatment efficacy, delivery, and access to services
• Mechanisms underlying sex differences in ASD (i.e., prevalence, biological mechanisms, phenotypic expression, core and comorbid syndrome expression and outcomes, developmental trajectories, diagnosis, and treatment response)
• Mechanisms underlying conditions co-occurring with ASD (e.g., sleep disturbances, gastrointestinal issues, inflammation, aggression, depression, anxiety, attention deficit, and seizures)
• Factors impacting quality of life during geographic relocation, such as military permanent change of station
• Long-term treatment outcomes from previous clinical trials for ASD core symptoms or to alleviate co-occurring conditions
• Create tools and strategies to increase the speed with which evidence-based practices are deployed in community-based settings
It is expected that four awards will be granted.
Funding: $550,000 total
Duration: 3 years
Research Authority due date: 16.5.22
Pre application (required) due date: 23.5.22
Full application due date: 18.8.22
